<?xml version="1.0" encoding="UTF-8"?>
<p>The first studies on nasal administration of zidovudine to rats were performed using formulations constituted by an aqueous suspension of AZT (20 Âµmol/kg) or a suspension of AZT and probenecid [
 <xref rid="B114-pharmaceutics-10-00039" ref-type="bibr">114</xref>]. Following nasal administration, AZT showed rapid absorption in the bloodstream and the CSF, even if the CSF/plasma ratio was lower than 1 and weakly increased in the presence of probenecid [
 <xref rid="B114-pharmaceutics-10-00039" ref-type="bibr">114</xref>].
</p>
